Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 29/100 | DilutionWatch score record |
| Shares Outstanding | 35.07M | Verified float table or market cache |
| Public Float | 16.88M | Verified float table or market cache |
| Market Cap | $361.19M | Market data cache |
| Cash Runway | Not applicable / unavailable | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | 111.0K | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 7.
Recent SEC source mix: 4 5, XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
FENC SEC Filing Activity — Last 12 Months
Shares outstanding reported by FENC on the cover page of its latest 10-K/10-Q: 35.07M as of August 11, 2026.
DilutionWatch recorded no shelf, registration or prospectus documents for FENC in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 8-K | current report (material event) | 8 | Jun 10, 2026 |
| 10-K | annual report | 1 | Mar 27, 2026 |
| 10-Q | quarterly report | 1 | May 14, 2026 |
| SC 13G/A | amended passive >5% holder filing | 3 | Oct 19, 2026 |
| 3 | initial insider ownership | 23 | Aug 31, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual FENC Dilution Snapshot
Fennec Pharmaceuticals Inc. (FENC) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 27, 2026.
- Stored outstanding warrants: 111,000.
- Recent SEC activity tracked for FENC: xbrl on 2026-08-13; 4 on 2026-04-02; 4 on 2026-04-02.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
FENC's DilutionScore is currently 29/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 33/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Sep 28 – Oct 27, 2026 | 29/100 | MEDIUM | 30 days |
| Aug 22 – Sep 27, 2026 | 33/100 | MEDIUM | 37 days |
| Aug 14 – Aug 21, 2026 | 36/100 | MEDIUM | 7 days |
| Jul 30 – Aug 13, 2026 | 33/100 | MEDIUM | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
FENC shares outstanding have increased 1.7% from 34.16M (Mar 2026) to 34.74M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 19, 2026 | 34.74M | 16.88M | ▲ 0.07% |
| May 18, 2026 | 34.74M | 16.87M | ▲ 0.47% |
| May 17, 2026 | 34.74M | 16.79M | ▼ 1.17% |
| May 15, 2026 | 34.71M | 16.99M | ▲ 0.16% |
| May 10, 2026 | 34.71M | 16.96M | ▲ 0.63% |
| May 01, 2026 | 34.71M | 16.86M | ▼ 10.52% |
| Apr 18, 2026 | 34.48M | 18.84M | ▲ 16.38% |
| Apr 07, 2026 | 34.48M | 16.19M | ▼ 14.49% |
| Mar 30, 2026 | 34.16M | 18.93M | ▲ 0.76% |
| Mar 29, 2026 | 34.16M | 18.79M | ▲ 0.91% |
| Mar 28, 2026 | 34.16M | 18.62M | ▼ 0.03% |
| Mar 27, 2026 | 34.16M | 18.62M | ▲ 0.02% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.